SciBase Holding AB (publ) (SCIB.ST)
SEK 0.37
(-6.03%)
SEK 0.37
(-6.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -51.82 Million SEK | -27.75% |
| 2022 | -39.32 Million SEK | -1.55% |
| 2021 | -38.58 Million SEK | -20.14% |
| 2020 | -32.18 Million SEK | 11.98% |
| 2019 | -36.43 Million SEK | 14.8% |
| 2018 | -43.17 Million SEK | -3.57% |
| 2017 | -41.7 Million SEK | 20.99% |
| 2016 | -52.75 Million SEK | -27.45% |
| 2015 | -41.36 Million SEK | -6.48% |
| 2014 | -38.54 Million SEK | -11.32% |
| 2013 | -34.39 Million SEK | -6.03% |
| 2012 | -32.95 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -13.78 Million SEK | -42.64% |
| 2024 Q1 | -10.78 Million SEK | 37.17% |
| 2023 Q2 | -13.82 Million SEK | -28.2% |
| 2023 FY | - SEK | -27.75% |
| 2023 Q4 | -15.83 Million SEK | -24.92% |
| 2023 Q3 | -12.67 Million SEK | 8.29% |
| 2023 Q1 | -10.78 Million SEK | 31.0% |
| 2022 Q1 | -9.69 Million SEK | 30.62% |
| 2022 Q4 | -15.62 Million SEK | -81.26% |
| 2022 FY | - SEK | -1.55% |
| 2022 Q2 | -9.22 Million SEK | 4.87% |
| 2022 Q3 | -8.62 Million SEK | 6.55% |
| 2021 Q1 | -8.11 Million SEK | 19.14% |
| 2021 FY | - SEK | -20.14% |
| 2021 Q4 | -13.97 Million SEK | -62.86% |
| 2021 Q3 | -8.58 Million SEK | 22.71% |
| 2021 Q2 | -11.1 Million SEK | -36.9% |
| 2020 Q1 | -8.86 Million SEK | 14.72% |
| 2020 FY | - SEK | 11.98% |
| 2020 Q4 | -10.03 Million SEK | -37.0% |
| 2020 Q3 | -7.32 Million SEK | 16.69% |
| 2020 Q2 | -8.78 Million SEK | 0.88% |
| 2019 FY | - SEK | 14.8% |
| 2019 Q4 | -10.39 Million SEK | -6.08% |
| 2019 Q3 | -9.8 Million SEK | 7.05% |
| 2019 Q2 | -10.54 Million SEK | -19.46% |
| 2019 Q1 | -8.82 Million SEK | 23.18% |
| 2018 Q2 | -10.23 Million SEK | -6.77% |
| 2018 Q4 | -11.49 Million SEK | 9.63% |
| 2018 Q1 | -9.58 Million SEK | 6.79% |
| 2018 FY | - SEK | -3.57% |
| 2018 Q3 | -12.71 Million SEK | -24.18% |
| 2017 FY | - SEK | 20.99% |
| 2017 Q2 | -11.71 Million SEK | -0.9% |
| 2017 Q4 | -10.28 Million SEK | -16.84% |
| 2017 Q1 | -11.6 Million SEK | 20.63% |
| 2017 Q3 | -8.8 Million SEK | 24.81% |
| 2016 Q1 | -11.59 Million SEK | -3.99% |
| 2016 Q3 | -12.39 Million SEK | 14.33% |
| 2016 Q2 | -14.46 Million SEK | -24.75% |
| 2016 Q4 | -14.62 Million SEK | -17.98% |
| 2016 FY | - SEK | -27.45% |
| 2015 Q3 | -10.26 Million SEK | 6.14% |
| 2015 Q2 | -10.93 Million SEK | -19.23% |
| 2015 Q1 | -9.16 Million SEK | 9.09% |
| 2015 FY | - SEK | -6.48% |
| 2015 Q4 | -11.15 Million SEK | -8.69% |
| 2014 Q3 | -7.93 Million SEK | 31.36% |
| 2014 Q4 | -10.08 Million SEK | -27.08% |
| 2014 Q2 | -11.56 Million SEK | -28.3% |
| 2014 Q1 | -9.01 Million SEK | 0.0% |
| 2014 FY | - SEK | -11.32% |
| 2013 FY | - SEK | -6.03% |
| 2012 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acarix AB (publ) | -77.12 Million SEK | 32.796% |
| ADDvise Group AB (publ) | 411.9 Million SEK | 112.583% |
| ADDvise Group AB (publ) | 411.9 Million SEK | 112.583% |
| Arcoma AB | 6.24 Million SEK | 929.529% |
| Bactiguard Holding AB (publ) | -89.98 Million SEK | 42.401% |
| BICO Group AB (publ) | 322.3 Million SEK | 116.081% |
| Boule Diagnostics AB (publ) | 65.97 Million SEK | 178.554% |
| CellaVision AB (publ) | 207.24 Million SEK | 125.009% |
| Clinical Laserthermia Systems AB (publ) | -68.4 Million SEK | 24.233% |
| Chordate Medical Holding AB (publ) | -27.94 Million SEK | -85.481% |
| C-Rad AB (publ) | 48.9 Million SEK | 205.981% |
| Duearity AB (publ) | -24.77 Million SEK | -109.165% |
| Dignitana AB (publ) | -264 Thousand SEK | -19532.197% |
| Episurf Medical AB (publ) | -87.7 Million SEK | 40.902% |
| Getinge AB (publ) | 5.92 Billion SEK | 100.874% |
| Scandinavian Real Heart AB (Publ) | -67.25 Million SEK | 22.931% |
| Iconovo AB (publ) | -35.33 Million SEK | -46.677% |
| Integrum AB (publ) | 8.76 Million SEK | 691.552% |
| Luxbright AB (publ) | -23.86 Million SEK | -117.16% |
| Mentice AB (publ) | 28.87 Million SEK | 279.507% |
| OssDsign AB (publ) | -122.02 Million SEK | 57.525% |
| Paxman AB (publ) | 31.22 Million SEK | 265.964% |
| Promimic AB (publ) | -3.68 Million SEK | -1306.868% |
| Qlife Holding AB (publ) | -150.5 Million SEK | 65.563% |
| ScandiDos AB (publ) | -13.35 Million SEK | -288.058% |
| Sectra AB (publ) | 615.06 Million SEK | 108.427% |
| Sedana Medical AB (publ) | -51.67 Million SEK | -0.3% |
| Senzime AB (publ) | -118.82 Million SEK | 56.381% |
| SpectraCure AB (publ) | -20.96 Million SEK | -147.17% |
| Stille AB | 56.04 Million SEK | 192.484% |
| Vitrolife AB (publ) | -3.18 Billion SEK | 98.373% |
| Xvivo Perfusion AB (publ) | 126.57 Million SEK | 140.948% |